| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.03B | +4.7% | +7.9% |
| Gross Profit | $609.5M | +5.1% | +6.5% |
| R&D Expense | $51.1M | +3.8% | +8.5% |
| SG&A Expense | $248.4M | +0.4% | +8.6% |
| Interest Expense | $17.7M | +5.5% | -4.9% |
| Pre-tax Income | $269.2M | +8.3% | +4.0% |
| Income Tax | $51.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $69.1M | +11.7% | -3.5% |
| Accounts Receivable | $687.3M | +0.8% | +7.9% |
| Inventory | $401.8M | +3.5% | +6.9% |
| Current Assets | $1.28B | +3.0% | +6.9% |
| Total Assets | $3.52B | +3.6% | +6.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $730.2M | — | — |
| Capital Expenditures | $65.6M | — | — |
| Investing Cash Flow | -$153.5M | — | — |
| Financing Cash Flow | -$563.0M | — | — |
| Free Cash Flow | $664.6M | — | — |
| +11.7% |
| +9.1% |
| Net Income | $217.5M | +7.5% | +2.8% |
| EPS (Basic) | $10.60 | +8.4% | +5.9% |
| EPS (Diluted) | $10.57 | +8.3% | +6.1% |
| $1.19B |
| +7.7% |
| +0.6% |
| Long-term Debt | $2.15B | +1.1% | +13.5% |
| Total Liabilities | $3.77B | +3.0% | +8.5% |
| Stockholders' Equity | -$249.2M | +3.7% | -61.4% |